Agios Pharmaceuticals (AGIO) Receivables - Net (2014 - 2021)

Agios Pharmaceuticals has reported Receivables - Net for 8 years, with the latest figure at $4.4 million in Q4 2021.

• For the quarter ending Q4 2021, Receivables - Net changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2021 stood at $4.4 million (changed N/A YoY), and the FY2021 full-year result was $4.4 million, changed N/A from the prior year.
• Receivables - Net for Q4 2021 stood at $4.4 million, up from $2.3 million in the prior quarter.
• The five-year high for Receivables - Net was $19.3 million in Q2 2018, with the low at $779000.0 in Q2 2017.
• Historically, Receivables - Net has averaged $3.7 million across 5 years, with a median of $2.5 million in 2019.
• Annual changes were most pronounced in 2018 — Receivables - Net soared 2380.87% — and 2019, when it sank 86.94%.
• Agios Pharmaceuticals' Receivables - Net stood at $2.4 million in 2017, then gained by 0.57% to $2.5 million in 2018, then plunged by 37.49% to $1.5 million in 2019, then surged by 51.66% to $2.3 million in 2020, then surged by 87.57% to $4.4 million in 2021.
• The last three Receivables - Net figures came in at $4.4 million (Q4 2021), $2.3 million (Q3 2020), and $2.5 million (Q2 2020), per Business Quant data.